6533b825fe1ef96bd1283470

RESEARCH PRODUCT

PGI19 Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists or Sucralfate: A Cost-Effectiveness Analysis

Myriam MartelAlan N. BarkunMarc BardouViviane Adam

subject

SucralfateHistamine H2 receptorbusiness.industryAnesthesiaStress ulcerHealth PolicyPublic Health Environmental and Occupational HealthMedicineCost-effectiveness analysisbusinessmedicine.diseasehealth care economics and organizationsmedicine.drug10.1016/j.jval.2011.08.890http://dx.doi.org/10.1016/j.jval.2011.08.890